Moderna Inc (MRNA)
41.12
+2.87
(+7.50%)
USD |
NASDAQ |
Nov 22, 16:00
41.35
+0.23
(+0.56%)
After-Hours: 20:00
Moderna Free Cash Flow: -3.956B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.956B |
| June 30, 2024 | -3.979B |
| March 31, 2024 | -3.672B |
| December 31, 2023 | -3.825B |
| September 30, 2023 | -2.657B |
| June 30, 2023 | -754.00M |
| March 31, 2023 | 612.00M |
| December 31, 2022 | 4.581B |
| September 30, 2022 | 6.201B |
| June 30, 2022 | 9.215B |
| March 31, 2022 | 13.03B |
| December 31, 2021 | 13.34B |
| Date | Value |
|---|---|
| September 30, 2021 | 11.39B |
| June 30, 2021 | 9.083B |
| March 31, 2021 | 5.007B |
| December 31, 2020 | 1.959B |
| September 30, 2020 | 612.84M |
| June 30, 2020 | -374.97M |
| March 31, 2020 | -451.14M |
| December 31, 2019 | -491.00M |
| September 30, 2019 | -489.50M |
| June 30, 2019 | -482.04M |
| March 31, 2019 | -445.20M |
| December 31, 2018 | -436.63M |
Free Cash Flow Range, Past 5 Years
-3.979B
Minimum
Jun 2024
13.34B
Maximum
Dec 2021
2.743B
Average
612.42M
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Merck & Co Inc | 14.84B |
| Pfizer Inc | 8.227B |
| Novavax Inc | -112.35M |
| Biogen Inc | 1.768B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.566B |
| Cash from Investing (Quarterly) | 721.00M |
| Cash from Financing (Quarterly) | 11.00M |
| Free Cash Flow Per Share (Quarterly) | -4.303 |
| Free Cash Flow to Equity (Quarterly) | -1.717B |
| Free Cash Flow to Firm (Quarterly) | -1.717B |
| Free Cash Flow Yield | -24.88% |